Sabrina Audagnotto

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. ncbi request reprint Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
    Francesco Giuseppe De Rosa
    Department of Medical Sciences, Infectious Diseases, Amedeo di Savoia Hospital, University of Turin, Corso Svizzera 164, 10149 Turin, Italy
    BMC Infect Dis 13:563. 2013
  2. pmc Mortality in patients with early- or late-onset candidaemia
    Francesco Giuseppe De Rosa
    Department of Medical Sciences, Infectious Diseases at Amedeo di Savoia Hospital, University of Turin, Turin, Italy
    J Antimicrob Chemother 68:927-35. 2013
  3. doi request reprint The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria
    F G De Rosa
    Department of Infectious Diseases, Amedeo di Savoia Hospital, University of Torino, Corso Svizzera 164, 10149 Turin, Italy
    Infection 39:555-61. 2011
  4. ncbi request reprint SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, Italy
    Francesco G De Rosa
    Universita di Torino, Dipartimento di Discipline Medico Chirurgiche, Sezione di Malattie Infettive, Ospedale Amedeo di Savoia, Italy
    New Microbiol 31:81-7. 2008
  5. ncbi request reprint Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users
    Francesco G De Rosa
    Department of Infectious Diseases, University of Turin, Turin, Italy
    Clin Infect Dis 45:583-8. 2007
  6. ncbi request reprint Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients
    F G De Rosa
    Clinica Malattie Infettive, Ospedale Amedeo di Savoia, Universita di Torino, Corso Svizzera 164, 10149 Torino, Italy
    Infection 35:154-60. 2007
  7. ncbi request reprint The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b
    Francesco G De Rosa
    Clinica Malattie Infettive, Universita di Torino, Turin, Italy
    Antivir Ther 11:165-71. 2006
  8. ncbi request reprint Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient
    Francesco G De Rosa
    Department of Infectious Diseases, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera 164, 10149, Turin, Italy
    J Infect 53:e215-8. 2006
  9. ncbi request reprint Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C
    Francesco G De Rosa
    Department of Infectious Diseases, University of Turin, Turin, Italy
    J Antimicrob Chemother 57:360-3. 2006
  10. doi request reprint Anidulafungin treatment in a kidney transplant recipient with hepatic damage
    Francesco G De Rosa
    Infectious Diseases Department, Ospedale Amedeo di Savoia, University of Turin, Italy
    Mycoses 54:12-5. 2011

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
    Francesco Giuseppe De Rosa
    Department of Medical Sciences, Infectious Diseases, Amedeo di Savoia Hospital, University of Turin, Corso Svizzera 164, 10149 Turin, Italy
    BMC Infect Dis 13:563. 2013
    ..The objective of our study was to report the incidence and the etiology of bloodstream infections in patients with AML undergoing levofloxacin prophylaxis during neutropenic episodes...
  2. pmc Mortality in patients with early- or late-onset candidaemia
    Francesco Giuseppe De Rosa
    Department of Medical Sciences, Infectious Diseases at Amedeo di Savoia Hospital, University of Turin, Turin, Italy
    J Antimicrob Chemother 68:927-35. 2013
    ..In this paper, we compared the risk factors for mortality according to the onset of candidaemia...
  3. doi request reprint The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria
    F G De Rosa
    Department of Infectious Diseases, Amedeo di Savoia Hospital, University of Torino, Corso Svizzera 164, 10149 Turin, Italy
    Infection 39:555-61. 2011
    ..To describe the impact of empiric appropriate treatment and the risk factors associated with mortality in patients with bacteremia by E. coli, K. pneumoniae and P. mirabilis producing ESBL...
  4. ncbi request reprint SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, Italy
    Francesco G De Rosa
    Universita di Torino, Dipartimento di Discipline Medico Chirurgiche, Sezione di Malattie Infettive, Ospedale Amedeo di Savoia, Italy
    New Microbiol 31:81-7. 2008
    ..In our experience, this Regional survey stimulated further research and collaboration to improve the prophylaxis, diagnosis and treatment of ICU-acquired infections...
  5. ncbi request reprint Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users
    Francesco G De Rosa
    Department of Infectious Diseases, University of Turin, Turin, Italy
    Clin Infect Dis 45:583-8. 2007
    ..022). A 12-week regimen of pegylated IFN to treat injection drug users with hepatitis C has a compliance that is much higher than that reported with a 24-week regimen. Adverse effects are minimal if patients are carefully selected...
  6. ncbi request reprint Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients
    F G De Rosa
    Clinica Malattie Infettive, Ospedale Amedeo di Savoia, Universita di Torino, Corso Svizzera 164, 10149 Torino, Italy
    Infection 35:154-60. 2007
    ..Intravenous drug users (IDUs) are at increased risk of infective endocarditis (IE)...
  7. ncbi request reprint The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b
    Francesco G De Rosa
    Clinica Malattie Infettive, Universita di Torino, Turin, Italy
    Antivir Ther 11:165-71. 2006
    ..Efforts should be made to propose a 12-week treatment with peg-IFN-alpha2b for AHC, and to maximize peg-IFN dosage. Early treatment is associated with early disappearance of HCV RNA...
  8. ncbi request reprint Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient
    Francesco G De Rosa
    Department of Infectious Diseases, University of Turin, Amedeo di Savoia Hospital, Corso Svizzera 164, 10149, Turin, Italy
    J Infect 53:e215-8. 2006
    ..We describe a patient with HIV-HCV coinfection with persistent disappearance of HCV-RNA after immunological and virological response to HAART, and we briefly discuss similar cases reported in the literature...
  9. ncbi request reprint Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C
    Francesco G De Rosa
    Department of Infectious Diseases, University of Turin, Turin, Italy
    J Antimicrob Chemother 57:360-3. 2006
    ..A 24 week treatment with pegylated IFN (PEG-IFN) alpha-2b is also effective. This study was designed to assess response rates to a 12 week regimen of PEG-IFN alpha-2b...
  10. doi request reprint Anidulafungin treatment in a kidney transplant recipient with hepatic damage
    Francesco G De Rosa
    Infectious Diseases Department, Ospedale Amedeo di Savoia, University of Turin, Italy
    Mycoses 54:12-5. 2011
    ..Anidulafungin was chosen when liver function test was abnormal in a setting of multiple causes of liver toxicity...
  11. ncbi request reprint Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy
    Giovanni Di Perri
    Department of Infectious Diseases, University of Torino, Turin, Italy
    Expert Opin Drug Saf 4:821-36. 2005
    ..Current guidelines, as well as additional possible strategies to be adopted in this particular co-morbidity setting are discussed...
  12. ncbi request reprint High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis
    Andrea Calcagno
    Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy
    J Antimicrob Chemother 69:241-5. 2014
    ..To analyse the determinants of raltegravir CSF penetration, including the pharmacogenetics of drug transporters located at the blood-brain barrier or blood-CSF barrier...
  13. ncbi request reprint Chemosusceptibility analysis of Plasmodium falciparum imported malaria in Italy
    Pietro Caramello
    Divisione A di Malattie Infettive, Dipartimento di Malattie Infettive, Ospedale Amedeo di Savoia, Turin, Italy
    Diagn Microbiol Infect Dis 52:107-12. 2005
    ..38, P < 0.05). Lower levels of chloroquine resistance were observed in 2000-2003 as compared with prior data; thus, the reemergence of chloroquine susceptibility in Africa may be hypothesized...
  14. ncbi request reprint Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis
    Stefano Bonora
    Department of Infectious Diseases, University of Turin, Turin, Italy
    Clin Infect Dis 36:1492-5. 2003
    ..All patients who recovered cleared 14-3-3 protein from the CSF before discharge from the hospital (this was the first CSF marker to clear), whereas those who died never cleared the protein...
  15. pmc Blackwater fever in children, Burundi
    Federico Gobbi
    Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Turin, Italy
    Emerg Infect Dis 11:1118-20. 2005
    ..Its pathogenesis and management are still debated. Nine cases of this syndrome occurred in 2003 at Kiremba Hospital in Burundi in children receiving multiple quinine treatments...
  16. ncbi request reprint Treatment of acute C hepatitis in intravenous drug users
    Olivia Bargiacchi
    J Hepatol 43:186-7. 2005
  17. ncbi request reprint Treatment of acute C hepatitis in HIV-infected patients
    Sabrina Audagnotto
    J Acquir Immune Defic Syndr 40:110-1. 2005
  18. ncbi request reprint Intrapulmonary concentrations of cefepime
    Francesco G De Rosa
    Crit Care Med 32:1238; author reply 1238-9. 2004
  19. ncbi request reprint [Ertapenem. A new carbapenem in a single dose for community acquired infection]
    Giovanni Di Perri
    Clinica di Malattie Infettive, Universita degli Studi di Torino
    Ann Ital Med Int 20:3 p following 204. 2005
  20. ncbi request reprint Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitors
    Marta Boffito
    Clin Infect Dis 34:558-9. 2002